BCL2A1 and ovarian cancer: By analyzing The Cancer Genome Atlas (TCGA) datasets, we found a 4-fold increase in the BCL2A1 mRNA levels in ovarian cancer samples compared with normal ovary samples (Supplementary Figure S3).